Coastar Therapeutics Closes Seed Round Venture Funding

News Coastar Therapeutics Closes Seed Round Venture Funding SAN DIEGO, June 30, 2021 – Coastar Therapeutics Inc., an emerging biotech company focused on biological payload delivery technology for cancer immunotherapy and gene therapy, today announced that it has successfully closed seed round funding. “This is a historical moment for Coastar, and we are truly grateful […]

Coastar Therapeutics to Attend Cancer Virotherapy Conferences

Coastar Therapeutics Inc., an emerging biotech company focused on biological payload delivery technology for cancer immunotherapy and gene therapy, today announced that it is attending the 6th Oncolytic Virotherapy Summit on October 26-28 in Boston, Massachusetts and the International Oncolytic Virus Conference (IOVC) on November 5-7 in Sedona, Arizona.

Coastar Therapeutics to Present at JP Morgan Conference 2022

News Coastar Therapeutics to Present at JP Morgan Conference 2022 SAN DIEGO, Jan 3, 2022 – Coastar Therapeutics Inc., an emerging biotech company focused on biological payload delivery technology for cancer immunotherapy and gene therapy, today announced that it is presenting virtually at the Biotech Showcase™ 2022 conference with an online presentation. Eddie Y. Chung, […]